The remaining case (#5) displayed the same KRAS mutation between the primary and the recurrence, but a different morphology, being the primary a conventional pancreatic ductal adenocarcinoma and the relapse a pancreatic ductal adenocarcinoma with micropapillary features. This evidence concerns the gene KRAS and pancreatic ductal adenocarcinoma.